Apnimed Acquires Global Rights to Sulthiame for Sleep and Breathing Disorders
Details : Through the acqusition, Apnimed will focus on clinical development of Ospolot (sulthiame), which is being evaluated in mid-stage for the treament of obstructive sleep apnea.
Product Name : Ospolot
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
April 25, 2025
Efficacy, Safety and Tolerability of Sulthiame in Patients With Obstructive Sleep Apnea (OSA)
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
February 11, 2022
Pharmacokinetics and Tolerability of Sulthiame
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
January 17, 2018
Reset All
